semaglutide and beta blockers For a type 2 diabetic patient with eGFR ≈40 mL/min/1.73 m² who is taking metformin, a sulfonylurea, basal insulin, an SGLT2 inhibitor, an ACE‑inhibitor/ARB, a beta‑blocker, a diuretic, a statin, how These highlights do not include
Description
Additionally, metformin requires regular kidney function monitoring, and patients with declining renal function may need to reduce or eliminate it regardless of other medications

Semaglutide, marketed as Ozempic for diabetes and Wegovy for weight loss, has become one of the most widely recognized GLP-1 medications

1170 Rennison, H

This guide explains what research shows about combining these treatments

Consult with a healthcare professional to discuss any concerns and receive personalized guidance
